HUTCHMED (China) (LSE:HCM) Days Payable : 47.17 (As of Dec. 2023)

View and export this data going back to 2006. Start your Free Trial

What is HUTCHMED (China) Days Payable?

HUTCHMED (China)'s average Accounts Payable for the six months ended in Dec. 2023 was £36.0 Mil. HUTCHMED (China)'s Cost of Goods Sold for the six months ended in Dec. 2023 was £139.1 Mil. Hence, HUTCHMED (China)'s Days Payable for the six months ended in Dec. 2023 was 47.17.

The historical rank and industry rank for HUTCHMED (China)'s Days Payable or its related term are showing as below:

LSE:HCM' s Days Payable Range Over the Past 10 Years
Min: 51.2 Med: 62.75 Max: 97.51
Current: 52.13

During the past 13 years, HUTCHMED (China)'s highest Days Payable was 97.51. The lowest was 51.20. And the median was 62.75.

LSE:HCM's Days Payable is ranked worse than
72.57% of 977 companies
in the Drug Manufacturers industry
Industry Median: 86.23 vs LSE:HCM: 52.13

HUTCHMED (China)'s Days Payable declined from Dec. 2022 (63.83) to Dec. 2023 (47.17). It may suggest that HUTCHMED (China) accelerated paying its suppliers.

HUTCHMED (China) Days Payable Historical Data

The historical data trend for HUTCHMED (China)'s Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HUTCHMED (China) Days Payable Chart

HUTCHMED (China) Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Payable

Get a 7-Day Free Trial

57.54

54.39

51.20

63.84

52.33

HUTCHMED (China) Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Days Payable	Get a 7-Day Free Trial															46.11	59.23	63.83	56.20	47.17

Competitive Comparison of HUTCHMED (China)'s Days Payable

For the Drug Manufacturers - Specialty & Generic subindustry, HUTCHMED (China)'s Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

HUTCHMED (China)'s Days Payable Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, HUTCHMED (China)'s Days Payable distribution charts can be found below:

* The bar in red indicates where HUTCHMED (China)'s Days Payable falls into.

HUTCHMED (China) Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

HUTCHMED (China)'s Days Payable for the fiscal year that ended in Dec. 2023 is calculated as

	Days Payable (A: Dec. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2022 )	+	Accounts Payable (A: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2023 )	*	Days in Period
=	( (58.385	+	28.698)	/	2 )	/	303.713	*	365
=	43.5415					/	303.713	*	365
=	52.33

HUTCHMED (China)'s Days Payable for the quarter that ended in Dec. 2023 is calculated as:

	Days Payable (Q: Dec. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Jun. 2023 )	+	Accounts Payable (Q: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (Q: Dec. 2023 )	*	Days in Period
=	( (43.223	+	28.698)	/	2 )	/	139.137	*	365 / 2
=	35.9605					/	139.137	*	365 / 2
=	47.17

HUTCHMED (China) Days Payable Related Terms

Thank you for viewing the detailed overview of HUTCHMED (China)'s Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

HUTCHMED (China) (LSE:HCM) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » HUTCHMED (China) Ltd (LSE:HCM) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

HCM:USA 00013:Hong Kong HCM.GB:UK H7T2:Germany

Address

2 Queen's Road Central, 48th Floor, Cheung Kong Center, Hong Kong, HKG

Website

https://www.hutch-med.com

HUTCHMED (China) Ltd is an innovative biopharmaceutical company engaged in the discovery, global development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies around the world and extensive commercial infrastructure in its home market of China. The company operates in two reportable segments Oncology/Immunology, and Other Ventures.